These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4152320)

  • 41. Synthesis of novel lincomycin derivatives and their in vitro antibacterial activities.
    Umemura E; Wakiyama Y; Kumura K; Ueda K; Masaki S; Watanabe T; Yamamoto M; Hirai Y; Fushimi H; Yoshida T; Ajito K
    J Antibiot (Tokyo); 2013 Mar; 66(3):195-8. PubMed ID: 23232934
    [No Abstract]   [Full Text] [Related]  

  • 42. The antibacterial effect of halothane.
    Fox C; Whyte A; Walker G; Wedgewood J
    J Hosp Infect; 1993 Jan; 23(1):73-5. PubMed ID: 8095953
    [No Abstract]   [Full Text] [Related]  

  • 43. [In vitro antibacterial activities of cefteram and other beta-lactam agents against recent clinical isolates].
    Yamaguchi K; Ohno A; Takahashi S; Hayashi M; Yamanaka K; Hirakata Y; Mitsuyama J
    Jpn J Antibiot; 1998 Jan; 51(1):11-25. PubMed ID: 9557273
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rifampicin: a new rifamycin. I. Bacteriological studies.
    Arioli V; Pallanza R; Furesz S; Carniti G
    Arzneimittelforschung; 1967 May; 17(5):523-9. PubMed ID: 4385644
    [No Abstract]   [Full Text] [Related]  

  • 45. Subconjunctival antibiotic therapy in ophthalmology with special consideration of the penicillins and cephalosporins.
    Records RE; Ellis PP
    Trans Pac Coast Otoophthalmol Soc Annu Meet; 1969; 50():179-93. PubMed ID: 4395536
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effect of spiramycin on the pathogenicity and growth of gram positive bacteria].
    Taranger C; Pons M; Tamalet J; Videau D
    Pathol Biol (Paris); 1972 Dec; 20(23):961-4. PubMed ID: 4405485
    [No Abstract]   [Full Text] [Related]  

  • 47. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
    Melo-Cristino J; Fernandes ML; Serrano N;
    Acta Med Port; 2001; 14(5-6):459-68. PubMed ID: 11878155
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study.
    Brown SD; Rybak MJ
    J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i7-15. PubMed ID: 15265831
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program.
    Beekmann SE; Heilmann KP; Richter SS; García-de-Lomas J; Doern GV;
    Int J Antimicrob Agents; 2005 Feb; 25(2):148-56. PubMed ID: 15664485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antimicrobial agents--mechanisms of action and clinical usage.
    Neu HC
    Curr Probl Surg; 1973 Jun; ():1-64. PubMed ID: 4146368
    [No Abstract]   [Full Text] [Related]  

  • 51. [Susceptibility of bacteria isolated from lower respiratory tract infections to antibiotics (1983)].
    Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Saito A; Shinohara M; Matsumiya H; Ueda K; Ida S
    Jpn J Antibiot; 1985 Nov; 38(11):3119-44. PubMed ID: 3937915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Antimicrobial activity of cefodizime against clinical isolates].
    Suzuki Y; Ishihara R; Ishii Y; Nakazawa A; Deguchi K; Matsumoto Y; Nishinari C; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1996 Oct; 49(10):947-65. PubMed ID: 8986558
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A multicenter study of the antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, and Moraxella catarrhalis from community acquired infections in Saitama, Japan].
    Yamaguchi T; Hashikita G; Ogino T; Yoshioka H; Shimojima M; Ikari H; Nose K; Mitsunori K; Watanabe N; Maesaki S
    Jpn J Antibiot; 2015 Oct; 68(5):275-84. PubMed ID: 26742285
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro and in vivo antibacterial activity of modithromycin against streptococci and Haemophilus influenzae.
    Sato T; Kawai Y; Matsuda H; Tateda K; Kimura S; Ishii Y; Yamaguchi K; Gotoh N
    J Antimicrob Chemother; 2011 Jul; 66(7):1547-54. PubMed ID: 21511823
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibacterial effects of Eucalyptus globulus leaf extract on pathogenic bacteria isolated from specimens of patients with respiratory tract disorders.
    Salari MH; Amine G; Shirazi MH; Hafezi R; Mohammadypour M
    Clin Microbiol Infect; 2006 Feb; 12(2):194-6. PubMed ID: 16441463
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 1-Alkyl-1-(2-mercaptoethyl)guanidines and the corresponding thioureas, disulfides, and thiosulfates as antibacterial agents.
    Westland RD; Karger ER; Green B; Dice JR
    J Med Chem; 1968 Jan; 11(1):84-6. PubMed ID: 4384131
    [No Abstract]   [Full Text] [Related]  

  • 57. [Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Pseudomonas aeruginosa isolated in major hospitals in Nagano prefecture].
    Hachiya T; Kubo K; Yanagisawa H
    Jpn J Antibiot; 2004 Apr; 57(2):157-71. PubMed ID: 15219055
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Analysis of the genes mediating antibiotic resistance in causative microorganisms of respiratory tract infections].
    Ubukata K
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():413-7. PubMed ID: 16416826
    [No Abstract]   [Full Text] [Related]  

  • 59. [Susceptibility of bacteria isolated from patients with lower respiratory tract infections to antibiotics (1987)].
    Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Kondou T; Saitou A; Matsumiya H; Ueda K; Terai T
    Jpn J Antibiot; 1990 Jan; 43(1):147-80. PubMed ID: 2112206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
    Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT
    J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.